168.
Slipped Capital Femoral Epiphysis in Denmark
Mathilde Pihl, Niels Ellitsgaard
Department of Orthopaedic Paediatric Surgery Hvidovre University Hospital;
Department of Orthopaedic Paediatric Surgery, Hvidovre University Hospital
Background:
Slipped Capital Femoral Epiphysis (SCFE) is an adolescence
hip disorder with a low prevalence. By July 1th 2011 the National Board of
Health centralized the treatment. Till then diagnosing and treatment was partly
performed on local orthopedic departments. As the parameters on SCFE have
not been analyzed in Denmark we found it necessary to describe them prior to
merging of treatment.
Purpose / Aim of Study:
The purpose of this study was to depict diagnosis,
treatment and complications to SCFE in Denmark. How do we find SCFEs?
Do we have a Danish standard? And what do we gain by centralizing?
Materials and Methods:
A questionnaire was sent to all 35 orthopaedic
departments, September 2010.
Findings / Results:
Nineteen of the 35 departments surveyed met SCFE
patients. The epidemiology was comparable to literature. Due to the diversity
of symptoms and the fact that the condition is rare, patients were often seen by
a GP as well as an orthopaedic surgeon prior to diagnosis, hence a delay. The
diagnostic tool was X-ray, classifications were many and no standard for
radiological diagnosis was found. One department used a standardized
hipscore to register the clinical examination, 5 departments had guidelines for
SCFE and 1 Region treated the children in specialized orthopaedic
departments. Four departments investigated risk factors. The treatment in
Denmark is adequate to the one found in literature, except for a tendency to
correct the position of the femur head before pinning. Complications are
similar to those described in literature, but in Denmark we have no standard of
treatment.
Conclusions:
Although comparable to the treatment taught by literature SCFE
treatment in Denmark needs a standardisation in diagnostics and classification.
Due to the merging suggested by the National Board of Health data for
standardisation will be easily accessible.
